About Masimo (NASDAQ:MASI)
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.
Industry, Sector and Symbol
Industry MED PRODS
Sub-IndustryHealth Care Equipment
Trailing P/E Ratio35.7459141776025
Forward P/E Ratio30.02
Sales & Book Value
Annual Sales$798.11 million
Price / Sales5.46
Cash Flow$2.99 per share
Price / Cash28.17
Book Value$13.68 per share
Price / Book6.17
Net Income$131.61 million
Return on Equity22.75%
Return on Assets17.54%
Masimo (NASDAQ:MASI) Frequently Asked Questions
What is Masimo's stock symbol?
Masimo trades on the NASDAQ under the ticker symbol "MASI."
How were Masimo's earnings last quarter?
Masimo Co. (NASDAQ:MASI) posted its quarterly earnings data on Tuesday, February, 27th. The medical equipment provider reported $0.72 EPS for the quarter, beating the consensus estimate of $0.61 by $0.11. The medical equipment provider had revenue of $225.20 million for the quarter, compared to the consensus estimate of $201.54 million. Masimo had a return on equity of 22.75% and a net margin of 16.49%. Masimo's revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.46 earnings per share. View Masimo's Earnings History.
When will Masimo make its next earnings announcement?
What guidance has Masimo issued on next quarter's earnings?
Masimo updated its FY18 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of $2.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.66. The company issued revenue guidance of $836.0 million, compared to the consensus revenue estimate of $832.07 million.
Where is Masimo's stock going? Where will Masimo's stock price be in 2018?
6 brokerages have issued 1 year price targets for Masimo's shares. Their forecasts range from $91.00 to $112.00. On average, they expect Masimo's share price to reach $102.17 in the next year. View Analyst Ratings for Masimo.
Who are some of Masimo's key competitors?
Some companies that are related to Masimo include Steris (STE), Bio-Rad Laboratories (BIO), West Pharmaceutical Services (WST), DexCom (DXCM), Hill-Rom (HRC), Gn Store Nord (GNNDY), ICU Medical (ICUI), Insulet (PODD), Globus Medical (GMED), Agios Pharmaceuticals (AGIO), Cantel Medical (CMD), Sartorius (SARTF), Hutchison China MediTech (HCM), Penumbra (PEN), LivaNova (LIVN), Haemonetics (HAE), ELEKTA (EKTAY) and Aurora Cannabis (ACBFF).
Who are Masimo's key executives?
Masimo's management team includes the folowing people:
- Joseph E. Kiani, Chairman of the Board, Chief Executive Officer (Age 52)
- Micah Young, Chief Financial Officer, Executive Vice President
- John Coleman, President - Worldwide Sales, Professional Services and Medical Affairs (Age 53)
- Rick Fishel, President - Worldwide OEM Business & Strategic Development (Age 59)
- Anand Sampath, Chief Operating Officer (Age 50)
- Yongsam Lee, Executive Vice President, Chief Information Officer (Age 52)
- Tom McClenahan, Executive Vice President, General Counsel, Corporate Secretary (Age 44)
- Steven J. Barker M.D., Ph.D., Director (Age 72)
- Sanford Fitch, Independent Director (Age 76)
- Thomas Harkin, Independent Director (Age 77)
Has Masimo been receiving favorable news coverage?
News coverage about MASI stock has been trending somewhat positive on Saturday, according to Accern Sentiment. Accern scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Masimo earned a media sentiment score of 0.01 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 44.25 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
Who are Masimo's major shareholders?
Masimo's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.03%), Acadian Asset Management LLC (2.04%), Bank of New York Mellon Corp (2.01%), Arrowstreet Capital Limited Partnership (1.93%), Robeco Institutional Asset Management B.V. (1.76%) and Old Mutual Global Investors UK Ltd. (1.71%). Company insiders that own Masimo stock include Anand Sampath, Joe E Kiani, Jon Coleman, Paul Jansen, Raad Mark De, Ramshorst David J Van, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Institutional Ownership Trends for Masimo.
Which major investors are selling Masimo stock?
MASI stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Two Sigma Advisers LP, Robeco Institutional Asset Management B.V., BlackRock Inc., Renaissance Technologies LLC, Arrowstreet Capital Limited Partnership, Goldman Sachs Group Inc. and Allianz Asset Management GmbH. Company insiders that have sold Masimo company stock in the last year include Anand Sampath, Joe E Kiani, Jon Coleman, Raad Mark De, Rick Fishel, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee. View Insider Buying and Selling for Masimo.
Which major investors are buying Masimo stock?
MASI stock was acquired by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Schroder Investment Management Group, American Century Companies Inc., Victory Capital Management Inc., Wells Fargo & Company MN, Old Mutual Global Investors UK Ltd., APG Asset Management N.V. and MetLife Investment Advisors LLC. View Insider Buying and Selling for Masimo.
How do I buy shares of Masimo?
Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Masimo's stock price today?
One share of MASI stock can currently be purchased for approximately $84.36.
How big of a company is Masimo?
Masimo has a market capitalization of $4.42 billion and generates $798.11 million in revenue each year. The medical equipment provider earns $131.61 million in net income (profit) each year or $2.36 on an earnings per share basis. Masimo employs 1,400 workers across the globe.
How can I contact Masimo?
Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at 949-297-7000 or via email at [email protected]
MarketBeat Community Rating for Masimo (MASI)MarketBeat's community ratings are surveys of what our community members think about Masimo and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Masimo (NASDAQ:MASI) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.83||2.80||2.57||2.57|
|Ratings Breakdown: ||0 Sell Rating(s)|
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$102.17||$106.25||$97.00||$97.00|
|Price Target Upside: ||21.11% upside||23.55% upside||12.79% upside||16.06% upside|
Masimo (NASDAQ:MASI) Consensus Price Target History
Masimo (NASDAQ:MASI) Analyst Ratings History
(Data available from 3/24/2016 forward)
Masimo (NASDAQ:MASI) Earnings History and Estimates Chart
Masimo (NASDAQ MASI) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/27/2018||Q4 2017||$0.61||$0.72||$201.54 million||$225.20 million||View||Listen|
|10/31/2017||Q3 2017||$0.53||$0.70||$189.01 million||$193.69 million||View||N/A|
|8/2/2017||Q2 2017||$0.71||$0.83||$189.03 million||$192.90 million||View||Listen|
|5/3/2017||Q1 2017||$0.60||$0.82||$184.14 million||$186.30 million||View||Listen|
|2/14/2017||Q416||$0.52||$0.51||$180.48 million||$183.20 million||View||Listen|
|11/2/2016||Q316||$0.42||$0.52||$165.51 million||$167.60 million||View||Listen|
|8/3/2016||Q216||$0.41||$0.57||$166.02 million||$172.64 million||View||Listen|
|5/4/2016||Q116||$0.43||$0.53||$165.25 million||$171.20 million||View||Listen|
|2/23/2016||Q415||$0.39||$0.15||$164.25 million||$167.30 million||View||Listen|
|11/5/2015||Q315||$0.31||$0.36||$149.31 million||$152.60 million||View||Listen|
|8/4/2015||Q215||$0.32||$0.43||$147.93 million||$155.73 million||View||Listen|
|5/6/2015||Q115||$0.35||$0.41||$151.00 million||$154.54 million||View||Listen|
|2/17/2015||Q414||$0.37||$0.40||$159.45 million||$161.80 million||View||Listen|
|10/29/2014||Q314||$0.25||$0.27||$144.20 million||$144.10 million||View||Listen|
|8/7/2014||Q214||$0.29||$0.27||$145.76 million||$140.92 million||View||Listen|
|4/30/2014||Q114||$0.29||$0.39||$144.01 million||$139.80 million||View||Listen|
|2/13/2014||Q413||$0.31||$0.31||$148.25 million||$134.70 million||View||Listen|
|10/30/2013||Q313||$0.26||$0.27||$132.47 million||$131.40 million||View||Listen|
|7/31/2013||Q2 2013||$0.28||$0.30||$136.36 million||$137.42 million||View||Listen|
|5/2/2013||Q1 2013||$0.28||$0.28||$134.46 million||$135.90 million||View||Listen|
|2/14/2013||Q4 2012||$0.29||$0.26||$129.09 million||$132.20 million||View||Listen|
|11/1/2012||Q312||$0.26||$0.26||$120.99 million||$112.10 million||View||N/A|
Masimo (NASDAQ:MASI) Earnings Estimates
2018 EPS Consensus Estimate: $2.53
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Masimo (NASDAQ:MASI)
No dividend announcements for this company have been tracked by MarketBeat.com
Masimo (NASDAQ MASI) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 16.60%
Institutional Ownership Percentage: 82.74%
Masimo (NASDAQ MASI) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/13/2018||Yongsam Lee||EVP||Sell||100||$90.00||$9,000.00||71,100|| |
|2/1/2018||Sanford Fitch||Director||Sell||2,000||$93.07||$186,140.00||68,249|| |
|2/1/2018||Yongsam Lee||EVP||Sell||10,000||$92.95||$929,500.00||79,000|| |
|1/25/2018||Sanford Fitch||Director||Sell||2,000||$90.00||$180,000.00||70,249|| |
|1/5/2018||Yongsam Lee||EVP||Sell||10,000||$88.17||$881,700.00||75,018|| |
|12/4/2017||Yongsam Lee||EVP||Sell||18,198||$88.85||$1,616,892.30||70,800|| |
|12/1/2017||Yongsam Lee||EVP||Sell||5,900||$88.31||$521,029.00||70,800|| |
|11/9/2017||Yongsam Lee||EVP||Sell||13,976||$89.43||$1,249,873.68||74,000|| |
|11/1/2017||Steven Barker||Director||Sell||10,000||$90.00||$900,000.00||73,249|| |
|11/1/2017||Yongsam Lee||EVP||Sell||5,000||$89.89||$449,450.00||74,000|| |
|8/17/2017||Sanford Fitch||Director||Sell||11,000||$87.25||$959,750.00||72,249|| |
|7/20/2017||Jon Coleman||Insider||Sell||25,000||$97.50||$2,437,500.00||32,201|| |
|7/14/2017||Rick Fishel||Insider||Sell||15,000||$94.85||$1,422,750.00||35,022|| |
|7/13/2017||Sanford Fitch||Director||Sell||6,000||$91.89||$551,340.00||89,249|| |
|7/11/2017||Anand Sampath||COO||Sell||40,000||$92.00||$3,680,000.00||20,000|| |
|7/11/2017||Rick Fishel||Insider||Sell||15,000||$92.85||$1,392,750.00||35,022|| |
|6/29/2017||Sanford Fitch||Director||Sell||14,000||$92.06||$1,288,840.00||90,249|| |
|5/1/2017||Joe E Kiani||CEO||Sell||145,841||$102.37||$14,929,743.17||165,082|| |
|4/28/2017||Thomas Samuel Mcclenahan||EVP||Sell||8,000||$102.75||$822,000.00||2,000|| |
|4/26/2017||Joe E Kiani||CEO||Sell||154,159||$99.70||$15,369,652.30||219,241|| |
|4/25/2017||Joe E Kiani||CEO||Sell||13,201||$101.00||$1,333,301.00||219,241|| |
|4/25/2017||Jon Coleman||Insider||Sell||50,000||$100.00||$5,000,000.00||14,682|| |
|4/25/2017||Yongsam Lee||EVP||Sell||10,000||$100.00||$1,000,000.00||79,000|| |
|4/24/2017||Joe E Kiani||CEO||Sell||100,000||$99.00||$9,900,000.00||219,241|| |
|4/24/2017||Thomas Samuel Mcclenahan||EVP||Sell||10,000||$98.75||$987,500.00||10,000|| |
|4/20/2017||Thomas Samuel Mcclenahan||EVP||Sell||10,000||$95.75||$957,500.00||4,000|| |
|4/19/2017||Yongsam Lee||EVP||Sell||10,000||$95.00||$950,000.00||79,000|| |
|4/4/2017||Raad Mark De||CFO||Sell||48,000||$93.25||$4,476,000.00||14,660|| |
|3/22/2017||Sanford Fitch||Director||Sell||3,000||$93.23||$279,690.00||80,000|| |
|3/10/2017||Paul Jansen||EVP||Sell||55,611||$94.47||$5,253,571.17||10,000|| |
|3/9/2017||Ramshorst David J Van||Insider||Sell||7,500||$94.20||$706,500.00||2,500|| |
|2/23/2017||Raad Mark De||CFO||Sell||30,000||$86.25||$2,587,500.00||17,660|| |
|2/17/2017||Raad Mark De||CFO||Sell||45,000||$80.00||$3,600,000.00||17,660|| |
|2/16/2017||Joe E Kiani||CEO||Sell||300,000||$80.04||$24,012,000.00||119,241|| |
|2/3/2017||Jon Coleman||Insider||Sell||6,000||$75.00||$450,000.00||13,182|| |
|2/3/2017||Raad Mark De||CFO||Sell||15,000||$75.00||$1,125,000.00||17,660|| |
|1/27/2017||Jon Coleman||Insider||Sell||5,800||$72.50||$420,500.00||8,707|| |
|1/27/2017||Raad Mark De||CFO||Sell||15,000||$72.50||$1,087,500.00||17,660|| |
|1/20/2017||Jon Coleman||Insider||Sell||200||$72.50||$14,500.00||7,282|| |
|1/13/2017||Yongsam Lee||EVP||Sell||10,000||$72.00||$720,000.00||79,000|| |
|1/10/2017||Jon Coleman||Insider||Sell||6,000||$70.00||$420,000.00||13,182|| |
|1/10/2017||Raad Mark De||CFO||Sell||15,000||$70.00||$1,050,000.00||17,660|| |
|1/10/2017||Yongsam Lee||EVP||Sell||10,000||$70.00||$700,000.00||79,000|| |
|1/9/2017||Paul Jansen||EVP||Sell||17,945||$68.88||$1,236,051.60||17,945|| |
|1/3/2017||Ramshorst David J Van||Insider||Sell||4,000||$67.20||$268,800.00||5,000|| |
|12/27/2016||Paul Jansen||EVP||Sell||2,055||$68.88||$141,548.40||2,055|| |
|12/21/2016||Jon Coleman||Insider||Sell||4,000||$67.50||$270,000.00||4,459|| |
|12/16/2016||Thomas Samuel Mcclenahan||EVP||Sell||10,000||$66.00||$660,000.00||10,000|| |
|12/8/2016||Paul Jansen||EVP||Sell||10,000||$63.88||$638,800.00||5,000|| |
|12/7/2016||Thomas Samuel Mcclenahan||EVP||Sell||2,293||$63.00||$144,459.00||4,000|| |
|12/6/2016||Joe E Kiani||CEO||Sell||52,859||$62.03||$3,278,843.77||119,241|| |
|12/6/2016||Thomas Samuel Mcclenahan||EVP||Sell||4,000||$63.00||$252,000.00||4,000|| |
|12/1/2016||Joe E Kiani||CEO||Sell||36,119||$62.06||$2,241,545.14||119,241|| |
|11/29/2016||Joe E Kiani||CEO||Sell||104,870||$62.27||$6,530,254.90||119,241|| |
|11/23/2016||Joe E Kiani||CEO||Sell||85,771||$62.06||$5,322,948.26||119,241|| |
|11/22/2016||Joe E Kiani||CEO||Sell||869||$62.00||$53,878.00||119,241|| |
|11/21/2016||Joe E Kiani||CEO||Sell||30,462||$62.04||$1,889,862.48||119,241|| |
|11/18/2016||Joe E Kiani||CEO||Sell||20,381||$62.02||$1,264,029.62||119,241|| |
|11/1/2016||Anand Sampath||COO||Sell||65,000||$55.04||$3,577,600.00||23,171|| |
|10/31/2016||Anand Sampath||COO||Sell||51,345||$55.05||$2,826,542.25||23,171|| |
|10/19/2016||Sanford Fitch||Director||Sell||2,000||$59.05||$118,100.00||46,000|| |
|10/10/2016||Joe E Kiani||CEO||Sell||84,617||$60.26||$5,099,020.42||126,450|| |
|10/10/2016||Yongsam Lee||EVP||Sell||30,000||$60.50||$1,815,000.00||93,000|| |
|10/5/2016||Sanford Fitch||Director||Sell||2,000||$59.58||$119,160.00||48,000|| |
|10/4/2016||Joe E Kiani||CEO||Sell||4,300||$60.07||$258,301.00||121,441|| |
|10/3/2016||Joe E Kiani||CEO||Sell||2,200||$60.00||$132,000.00||121,441|| |
|9/30/2016||Thomas Samuel Mcclenahan||EVP||Sell||10,000||$59.00||$590,000.00||10,000|| |
|9/27/2016||Joe E Kiani||CEO||Sell||4,464||$60.01||$267,884.64||123,705|| |
|9/22/2016||Joe E Kiani||CEO||Sell||49,484||$60.18||$2,977,947.12||158,911|| |
|9/21/2016||Sanford Fitch||Director||Sell||2,000||$59.41||$118,820.00||50,000|| |
|9/20/2016||Joe E Kiani||CEO||Sell||400||$60.16||$24,064.00||120,240|| |
|9/19/2016||Joe E Kiani||CEO||Sell||999||$60.03||$59,969.97||120,240|| |
|9/7/2016||Joe E Kiani||CEO||Sell||33,536||$60.00||$2,012,160.00||152,777|| |
|9/7/2016||Jon Coleman||Insider||Sell||6,000||$60.00||$360,000.00||759|| |
|9/7/2016||Sanford Fitch||Director||Sell||2,000||$59.81||$119,620.00|| |
|8/17/2016||Sanford Fitch||Director||Sell||2,000||$58.11||$116,220.00||54,000|| |
|8/4/2016||Jon Coleman||Insider||Sell||22,000||$56.82||$1,250,040.00||10,459|| |
|8/4/2016||Paul Jansen||EVP||Sell||10,000||$58.88||$588,800.00||10,000|| |
|8/3/2016||Sanford Fitch||Director||Sell||2,000||$52.62||$105,240.00||56,000|| |
|7/20/2016||Rick Fishel||Insider||Sell||22,000||$53.85||$1,184,700.00||42,022|| |
|7/20/2016||Sanford Fitch||Director||Sell||3,000||$53.48||$160,440.00||58,000|| |
|6/30/2016||Ramshorst David J Van||CAO||Sell||5,000||$52.50||$262,500.00||3,000|| |
|6/7/2016||Joe E Kiani||CEO||Sell||65,048||$50.00||$3,252,400.00||175,818|| |
|6/3/2016||Joe E Kiani||CEO||Sell||234,952||$50.09||$11,768,745.68||313,797|| |
|6/1/2016||Jon Coleman||Insider||Sell||4,000||$50.00||$200,000.00||4,459|| |
|5/31/2016||Raad Mark De||CFO||Sell||40,000||$49.43||$1,977,200.00||42,660|| |
|5/25/2016||Rick Fishel||Insider||Sell||25,000||$49.85||$1,246,250.00||52,022|| |
|5/5/2016||Jon Coleman||Insider||Sell||8,000||$47.00||$376,000.00||4,459|| |
|4/28/2016||Paul Jansen||EVP||Sell||10,000||$44.88||$448,800.00||10,000|| |
|4/27/2016||Jon Coleman||Insider||Sell||4,000||$44.00||$176,000.00||4,459|| |
|3/23/2016||Yongsam Lee||EVP||Sell||96,000||$39.96||$3,836,160.00||133,000|| |
|3/22/2016||Yongsam Lee||EVP||Sell||32,000||$40.06||$1,281,920.00||133,000|| |
|3/21/2016||Yongsam Lee||EVP||Sell||32,000||$39.83||$1,274,560.00||133,000|| |
|3/15/2016||Raad Mark De||CFO||Sell||40,000||$39.00||$1,560,000.00||42,660|| |
|2/29/2016||Raad Mark De||CFO||Sell||40,000||$38.11||$1,524,400.00||42,660|| |
|12/24/2015||Jon Coleman||insider||Sell||10,000||$42.00||$420,000.00||459|| |
|12/9/2015||Sanford Fitch||Director||Sell||2,000||$41.00||$82,000.00||61,000|| |
|11/11/2015||Sanford Fitch||Director||Sell||2,000||$42.67||$85,340.00||61,000|| |
|11/6/2015||Anand Sampath||COO||Sell||45,000||$42.00||$1,890,000.00|| |
|11/6/2015||Jon Coleman||insider||Sell||10,000||$42.38||$423,800.00||459|| |
|10/14/2015||Sanford Fitch||Director||Sell||2,000||$39.29||$78,580.00||61,000|| |
|9/17/2015||Paul Jansen||EVP||Sell||10,000||$42.88||$428,800.00|| |
|9/9/2015||Sanford Fitch||Director||Sell||2,000||$41.29||$82,580.00||61,000|| |
|8/31/2015||Thomas Samuel Mcclenahan||EVP||Sell||22,000||$40.62||$893,640.00|| |
|8/26/2015||Paul Jansen||EVP||Sell||10,000||$40.88||$408,800.00|| |
|7/22/2015||Rick Fishel||Insider||Sell||35,084||$41.85||$1,468,265.40|| |
|7/21/2015||Joe E Kiani||CEO||Sell||300,000||$40.55||$12,165,000.00|| |
|7/21/2015||Steven Barker||Director||Sell||20,000||$40.00||$800,000.00|| |
|7/8/2015||Sanford Fitch||Director||Sell||2,000||$38.18||$76,360.00|| |
|6/10/2015||Sanford Fitch||Director||Sell||2,000||$36.49||$72,980.00|| |
|6/4/2015||Steven Barker||Director||Sell||25,000||$36.20||$905,000.00|| |
|4/8/2015||Sanford Fitch||Director||Sell||2,000||$34.57||$69,140.00|| |
|2/18/2015||Rick Fishel||Insider||Sell||18,170||$29.85||$542,374.50|| |
|5/22/2013||Robert Coleman||Director||Sell||59,400||$21.93||$1,302,642.00|| |
Masimo (NASDAQ MASI) News Headlines
Masimo (NASDAQ:MASI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Masimo (NASDAQ:MASI) Income Statement, Balance Sheet and Cash Flow Statement
Masimo (NASDAQ MASI) Stock Chart for Saturday, March, 24, 2018